Ignite Creation Date:
2025-12-24 @ 4:07 PM
Ignite Modification Date:
2026-01-01 @ 9:39 AM
Study NCT ID:
NCT04005066
Status:
COMPLETED
Last Update Posted:
2022-12-19
First Post:
2019-04-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase IV Study of Elunate® (Fruquintinib) in Chinese Patients
Sponsor:
Hutchmed
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
2018-013-00CH2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None